Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study

Arthritis Care and Research

Volumn 63, Issue 11, 2011, Pages 1565-1570

  Varache, Sophie ^a   Narbonne, Valérie ^a   Jousse Joulin, Sandrine ^a   Guennoc, Xavier ^b   Dougados, Maxime ^c   Daurès, Jean Pierre ^d   Devauchelle Pensec, Valerie ^a   Saraux, Alain ^a,e  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b Saint Brieuc Hospital   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIV MONTPELLIER   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY;

ADULT; ARTICLE; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNITY; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SCREENING TEST; SYMPTOM;

ADULT; ANTIBODIES, VIRAL; ARTHRITIS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DNA, VIRAL; FEMALE; FRANCE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HIV-2; HUMANS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; VIRUS DISEASES;

EID: 80055069839     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20576     Document Type: Article

References (23)

1. Becker J, Winthrop KL,. Update on rheumatic manifestations of infectious diseases. Curr Opin Rheumatol 2010; 22: 72-7.
2. Vassilopoulos D, Calabrese LH,. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 2008; 10: 215.
3. Fransilla R, Hedman K,. Infection and musculoskeletal conditions: viral causes of arthritis. Best Pract Res Clin Rheumatol 2006; 20: 1139-57.
4. Youinou P, Pers JO, Gershwin ME, Shoenfeld Y,. Geo-epidemiology and autoimmunity. J Autoimmun 2010; 34: 163-7.
5. Guennoc X, Narbonne V, Jousse-Joulin S, Devauchelle-Pensec V, Dougados M, Daures JP, et al. Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study. J Rheumatol 2009; 36: 1407-13.
6. Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007; 74: 440-5. (Pubitemid 47588984)
7. Institut de Veille Sanitaire Rapport. Prévalence des hépatites B et C en France en 2004. 2007. URL:.
8. Cohen BJ, Buckley MM,. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151-3. (Pubitemid 18061270)
9. Roudot-Thoraval F,. Epidémiologie de l'hépatite C. Med Mal Infect 2000; 30 Suppl: 27-33.
10. Zerrak A, Bour JB, Tavernier C, Dougados M, Maillefert JF,. Usefulness of routine hepatitis C virus, hepatitis B virus, and parvovirus B19 serology in the diagnosis of recent-onset inflammatory arthritides [letter]. Arthritis Rheum 2005; 53: 477-8. (Pubitemid 40799892)
11. Posnett DN, Yarilin D,. Amplification of autoimmune disease by infection. Arthritis Res Ther 2005; 7: 74-84. (Pubitemid 40439442)
12. Takahashi Y, Murai C, Ishii T, Sugamura K, Sasaki T,. Human parvovirus B19 in rheumatoid arthritis. Int Rev Immunol 1998; 17: 309-21. (Pubitemid 29092126)
13. Stahl HD, Pfeiffer R, Von Salis-Soglio G, Emmrich F,. Parvovirus B19-associated mono- and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy. Clin Rheumatol 2000; 19: 510-1. (Pubitemid 32039679)
14. Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, et al. Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One 2010; 5: e13132.
15. Fautrel B, Saraux A, Maillefert JF, Kaye O, Lafforgue P, Flipo RM, et al, for the Club Rhumatisme & Inflammation of the French Society for Rheumatology. Costs of workups for the diagnosis of early arthritis: results of a nationwide survey. Arthritis Rheum 2004; 51: 507-12. (Pubitemid 39056235)
16. Pavy S, Constantin A, Pham T, Gossec L, Maillefert JF, Cantagrel A, et al. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 2006; 73: 388-95. (Pubitemid 44056248)
17. Calabrese LH, Zein NN, Vassilopoulos D,. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies. Ann Rheum Dis 2006; 65: 983-9. (Pubitemid 44133258)
18. Narvaez J, Rodriguez-Moreno J, Martinez-Aguila MD, Clavaguera MT,. Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy. J Rheumatol 1998; 25: 2037-8.
19. Fautrel B, Constantin A, Morel J, Vittecoq O, Cantagrel A, Combe B, et al. Recommendations of the French Society for Rheumatology: TNFα antagonist therapy in rheumatoid arthritis. Joint Bone Spine 2006; 73: 433-41. (Pubitemid 44038452)
20. Naides SJ,. Acute parvovirus B19-induced pancytopenia in the setting of methotrexate therapy for rheumatoid arthritis [letter]. Arthritis Rheum 1995; 38: 1023.
21. Koch WC, Massey G, Russell CE, Adler SP,. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr 1990; 116: 355-9. (Pubitemid 20109785)
22. Sharma VR, Fleming DR, Slone SP,. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood 2000; 96: 1184-6. (Pubitemid 30616893)
23. Saraux A, Fautrel B, Maillefert JF, Flipo RM, Kaye O, Lafforgue P, et al. Laboratory and imaging studies used by French rheumatologists to evaluate patients with early arthritis. J Rheumatol 2006; 33: 897-902.